Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WEST CHESTER, PA — Verrica Pharmaceuticals (Nasdaq: VRCA) has dosed the first U.S. patient in a second Phase 3 clinical trial evaluating YCANTH for common warts, expanding a late-stage development …
Verrica Advances Wart Treatment Program With Phase 3 Trial Expansion Read More
WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) has received U.S. Food and Drug Administration authorization for rolling review of its New Drug Application for QTORIN rapamycin, a step that could …
Palvella Secures FDA Rolling Review for Rare Disease Drug Read More
EXTON, PA — Omega Flex Inc. (NASDAQ: OFLX) declared a quarterly dividend of $0.34 per share, maintaining its shareholder payout while preserving flexibility to fund operations, capital investments and potential …
Omega Flex Maintains Dividend as Board Weighs Growth Needs Read More WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said it remains on track to submit a New Drug Application in the second half of 2026 for its lead therapy targeting …
Palvella Advances Rare Disease Drug Toward FDA Filing Read More
MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) has appointed healthcare sales executive Robert Greene as senior vice president of sales and awarded him restricted stock units valued at 200,000 shares, …
Neuronetics Names Sales Chief, Grants Equity Incentive Read More WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) will present its development strategy to investors this week as the clinical-stage biotechnology company advances a pipeline of experimental treatments targeting rare dermatological …
Palvella Set for Goldman Conference Amid Rare Disease Push Read More WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) has secured a new U.S. patent covering a key treatment approach for porokeratosis, strengthening its intellectual property position as the company prepares to …
Palvella Secures Patent Protection Ahead of Rare Skin Trial Read More
EXTON, PA — Innovative Aerosystems (Nasdaq: ISSC) will present at two investor conferences in June as the avionics manufacturer seeks to engage institutional investors and highlight its growth strategy across …
Innovative Aerosystems Courts Investors at June Conferences Read More WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) received the 2026 Healthcare & Life Sciences Company of the Year award from the Philadelphia Alliance for Capital and Technologies as the clinical-stage …
Palvella Wins PACT Award Amid Rare Disease Drug Push Read More WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) reported new late-stage clinical data showing strong patient response rates for its experimental QTORIN rapamycin treatment in rare vascular malformations, positioning the company …
Palvella Reports Late-Stage Success for Rare Disease Drug Read More